Piramal Enterprises is planning to raise Rs 750 crore through the issuance of Secured, Rated, Listed, Redeemable, Principal Protected, Market Linked Non-Convertible Debentures (NCDs) up to Rs 50 crore along with an option to retain oversubscription up to Rs 700 crore on a private placement basis. A meeting of the Administrative Committee of the Board of Directors of the Company will be held on September 23, 2022, to consider and approve the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
